Cargando…

Quantification of Maternal Serum Cell-Free Fetal DNA in Early-Onset Preeclampsia

The aim of this study was to determine whether the increased serum cell-free fetal DNA (cffDNA) level of gravidas developed into early-onset preeclampsia (EOPE) subsequently in the early second trimesters is related to prenatal screening markers. Serum was collected from 1011 gravidas. The level of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Hong, Shen, Yanting, Ge, Qinyu, He, Youji, Qiao, Dongyan, Ren, Mulan, Zhang, Jianqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645703/ https://www.ncbi.nlm.nih.gov/pubmed/23567271 http://dx.doi.org/10.3390/ijms14047571

Ejemplares similares

Profiling circulating microRNAs in maternal serum and plasma
por: GE, QINYU, et al.
Publicado: (2015)

The role of maternal serum catestatin in the evaluation of preeclampsia and fetal cardiac functions
por: Özalp, Miraç, et al.
Publicado: (2021)

Narrative review of the relationship between the maternal-fetal interface immune tolerance and the onset of preeclampsia
por: Luo, Fangyuan, et al.
Publicado: (2022)

Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation
por: Rafaeli-Yehudai, Tal, et al.
Publicado: (2018)

Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia
por: Hu, Mingjing, et al.
Publicado: (2019)

Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia?
por: Kim, Mi Jung, et al.
Publicado: (2017)

Oxidative stress in preeclampsia and the role of free fetal hemoglobin
por: Hansson, Stefan R., et al.
Publicado: (2015)

The Difference in Maternal Serum Hypoxia-Inducible Factors-1α Levels between Early Onset and Late-Onset Preeclampsia
por: Sriyanti, Roza, et al.
Publicado: (2019)

Maternal Serum Meteorin Levels and the Risk of Preeclampsia
por: Garcés, María F., et al.
Publicado: (2015)

Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infection
por: Sufriyana, Herdiantri, et al.
Publicado: (2022)

Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction
por: Youssef, Lina, et al.
Publicado: (2021)

Maternal Serum Cytokine Concentrations in Healthy Pregnancy and Preeclampsia
por: Spence, Toni, et al.
Publicado: (2021)

Different Profile of Serum Leptin between Early Onset and Late Onset Preeclampsia
por: Salimi, Saeedeh, et al.
Publicado: (2014)

Epistasis between COMT and MTHFR in Maternal-Fetal Dyads Increases Risk for Preeclampsia
por: Hill, Lori D., et al.
Publicado: (2011)

Differential Gene Expression at the Maternal-Fetal Interface in Preeclampsia Is Influenced by Gestational Age
por: Lian, Ingrid A., et al.
Publicado: (2013)

Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype
por: Banadakoppa, Manu, et al.
Publicado: (2020)

Proteomic Analysis of Maternal Urine for the Early Detection of Preeclampsia and Fetal Growth Restriction
por: Bujold, Emmanuel, et al.
Publicado: (2021)

High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia
por: Stefańska, Katarzyna, et al.
Publicado: (2023)

Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomia
por: GE, QINYU, et al.
Publicado: (2015)

Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction
por: Kwak, Dong Wook, et al.
Publicado: (2020)

Reduced Maternal Circulating Cell‐Free Mitochondrial DNA Is Associated With the Development of Preeclampsia
por: Cushen, Spencer C., et al.
Publicado: (2022)

FetalQuant(SD): accurate quantification of fetal DNA fraction by shallow-depth sequencing of maternal plasma DNA
por: Jiang, Peiyong, et al.
Publicado: (2016)

Association between the peripartum maternal and fetal telomere lengths and mitochondrial DNA copy numbers and preeclampsia: a prospective case–control study
por: Zhang, Ruyi, et al.
Publicado: (2022)

Relationship between Maternal Immunological Response during Pregnancy and Onset of Preeclampsia
por: Martínez-Varea, Alicia, et al.
Publicado: (2014)

Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia
por: Lazar, Levente, et al.
Publicado: (2009)

Evaluation of a Modified DNA Extraction Method for Isolation of Cell-Free Fetal DNA from Maternal Serum
por: Keshavarz, Zeinab, et al.
Publicado: (2015)

Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia
por: Chen, Hao, et al.
Publicado: (2022)

Maternal Steroids on Fetal Doppler Indices, in Growth-Restricted Fetuses with Abnormal Umbilical Flow from Pregnancies Complicated with Early-Onset Severe Preeclampsia
por: Tica, Oana Sorina, et al.
Publicado: (2023)

Fetal—Not Maternal—APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry
por: Reidy, Kimberly J., et al.
Publicado: (2018)

Association of Corpus Callosum Development With Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension
por: Zheng, Weizeng, et al.
Publicado: (2022)

Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition
por: Chang, Kai-Jung, et al.
Publicado: (2023)

Role of maternal serum interleukin 17 in preeclampsia: diagnosis and prognosis
por: El Shahaway, Alia A, et al.
Publicado: (2019)

Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia
por: Agabain, Eiman, et al.
Publicado: (2017)

A Systematic Review of Maternal Serum Syndecan-1 and Preeclampsia
por: George, Kitty, et al.
Publicado: (2022)

Cell Free Expression of hif1α and p21 in Maternal Peripheral Blood as a Marker for Preeclampsia and Fetal Growth Restriction
por: Ashur-Fabian, Osnat, et al.
Publicado: (2012)

Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study
por: Alahakoon, Thushari I., et al.
Publicado: (2020)

“Abnormal Analyte Preeclampsia”: Do the second trimester maternal serum analytes help differentiate preeclampsia subtypes?
por: CRITCHFIELD, Agatha S, et al.
Publicado: (2013)

Maternal anxiety forecasts shorter prolongation of pregnancies complicated by early-onset preeclampsia
por: van Esch, Joris J. A., et al.
Publicado: (2022)

Clinical Value of Serum SIRT1 Combined with Uterine Hemodynamics in Predicting Disease Severity and Fetal Growth Restriction in Preeclampsia
por: Ge, Tong Jun, et al.
Publicado: (2023)

Preeclampsia and Fetal Congenital Heart Defects
por: Ferreira, Bárbara D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i5mkl4p3nci0sfemnv5beeqclr